Pembrolizumab - Wikipedia
WEBPembrolizumab, sold under the brand name Keytruda, is a humanized antibody used in cancer immunotherapy that treats melanoma, lung cancer, head and neck cancer, Hodgkin lymphoma, stomach cancer, cervical cancer, and certain types of breast cancer. It is administered by slow intravenous injection.
Pembrolizumab: Uses, Dosage, Side Effects & Warning - Drugs.com
WEBPembrolizumab ( Keytruda) is a type of immunotherapy used to treat cancers, including lung cancer, breast cancer, melanoma, head and neck cancer, and many more. Pembrolizumab works by helping your immune system to slow or stop the growth and spread of cancer cells in the body.
KEYTRUDA® (pembrolizumab) - Official Site
WEBKEYTRUDA is a prescription medicine used to treat: a kind of lung cancer called non–small cell lung cancer (NSCLC). a kind of skin cancer called melanoma. a kind of cancer called head and neck squamous cell cancer (HNSCC). a kind of bladder and urinary tract cancer called urothelial cancer.
Pembrolizumab - NCI - National Cancer Institute
WEBUpdated: February 1, 2024. Pembrolizumab is a type of targeted therapy drug called an immune checkpoint inhibitor (a type of immunotherapy). It is a monoclonal antibody that binds to the protein PD-1 on the surface of immune cells called T cells. It works by keeping cancer cells from suppressing the immune system.
Pembrolizumab - StatPearls - NCBI Bookshelf
WEBJun 26, 2023 · Pembrolizumab is a humanized monoclonal IgG4 kappa antibody directed against human cell surface PD-1 (programmed death receptor-1) on lymphocytes. The PD-1 receptor provides an important “immune checkpoint,” which helps prevent the immune system from attacking itself.
Keytruda: Uses, Dosage, Side Effects, Warnings - Drugs.com
WEBDec 28, 2023 · Keytruda (pembrolizumab) is a type of immunotherapy that is given by intravenous (into a vein) infusion over 30 minutes to treat many different types of cancer such as melanoma, lung cancer, and some lymphomas (see below for the full list of cancers Keytruda is approved for).
Pembrolizumab (Keytruda) | Cancer information - Cancer …
WEBPembrolizumab is a type of immunotherapy . It stimulates the body's immune system to fight cancer cells. Pembrolizumab targets and blocks a protein called PD-1 on the surface of certain immune cells called T cells . Blocking PD-1 triggers the T cells to find and kill cancer cells.
Pembrolizumab (Keytruda): Uses & Side Effects - Cleveland Clinic
WEBPembrolizumab is a monoclonal antibody that treats certain types of cancer. The brand name of this medication is Keytruda®. A healthcare provider will give you this infusion in a hospital or clinic setting.
pembrolizumab (KEYTRUDA) | FDA
WEBThe recommended dose and schedule of pembrolizumab for this indication is 200 mg administered as an intravenous infusion over 30 minutes every 3 weeks. The current indication was approved under...
FDA approves pembrolizumab as adjuvant treatment for non …
WEBOn January 26, 2023, the Food and Drug Administration (FDA) approved pembrolizumab (Keytruda, Merck) for adjuvant treatment following resection and platinum-based chemotherapy for stage IB (T2a...
Skip to content